Already hold CNCE and bought more at 12.25. That stock will go no lower than that price ever again. At or near 15.00 now and that is only 1$ above IPO price a year ago. That is a steal and I keep adding. Why ?
They get to carry the indications from AVNR over to the buyout company Otsuka, they are a big name in biotech. They are getting ready to ann. a new indication for testing, have celgene, and Jazz phama as partners. They r one of only two deteriorate type biotehs around. That is a big big deal, go read about it. Soewhat the future of medicine.
They r now settled in and ready to really take off. Should see 25 before the end of the year (easily) and hold it. The celgene colaboration will be really big as the indication will accept what they r doing. Jazz on the other hand, who knows as GHB being detetiorated may not matter. Even bad ajzz news will just offer a buying oppurtunity.
INSM - Buyout type. Have their niche and going to the market with it. It will sell and they will make money. Look for buyout on it as that is all they have, one product wonder and those type can't sit on the market by themselves without some big pharma eyeballing the product and future sales. In at 14.25 and at 17.61. Look for buyout in the 27.00 range
BLCM - upside down quite a bit as bought at 30 and 23. So I am down about 15%. I bought on the IPO news, and Baker Brothers adding. Just bought too soon on excitment as it rode the wave up to 34 because it is latched with KITE, BLUE, and JUNO. All are doing the same thing, BLCM is the one without safety issues and they have a switch that all made have to buy. You can't continue inducing cell therapy when it kills because of toxicity. You need a way to stop it on a dime during procedure, basically in layman terms, that is WHAT BLCM has, a way to nuetralize the cells ASAP. JUNO is the hyped, PR one of the group, ran by the scum from Dedendron who went bankrupt. Amazingly the top people set up JUNO to open now, took their money from DNDN and now work here. Look for them to do the same stuff, BS PR blast, wrong news and dumping of shares. Good short oppurtunity if timing is right. Kite and BLUE are legit, kitei s leader in area IMO and kite hs the brains of oldtimers, yet, can see them moving slow as a retirement business.
INCY - In since 74, so up a little... REV was terrible, and as usual, bad rev and leading guidence means PPS goes up. No one cares how much you make, only what you tell me you can make in the future.
In realitty, all biotechs are way over priced. NONe are really worth what they trade at. Just people buying stocks and hope. If someone asked me who I would own for the future, and was stable, Regeneron, Novartis, and Celegene are going to be big, or stay big...
Hot Forum Topics
